Gadobutrol Injection
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Open FDA's page for this record- Discontinued date
- 06/30/2026
- Update type
- New
- Initial posting date
- 06/30/2026
- Package NDC
- 65219-281-02
- Generic name
- Gadobutrol Injection
- Contact info
- 888-386-1300
- Update date
- 06/30/2026
- Dosage form
- Injection
- Presentation
- Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-02)
- Company name
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Status
- To Be Discontinued
- Related info
Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA
- Therapeutic category
- Medical Imaging
- Harmonized identifiers (openFDA)
- Application number
- ANDA215061
- Brand name
- GADOBUTROL
- Generic name
- GADOBUTROL
- Manufacturer name
- Fresenius Kabi USA, LLC
- Product NDC
- 65219-281
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- GADOBUTROL
- SPL ID
- 490c8c3e-3195-40af-8f34-40d8df2719c3
- SPL set ID
- 007696d0-4b62-4937-9640-4ad619504df4
- Package NDC
- 65219-281-00, 65219-281-02, 65219-281-03, 65219-281-07, 65219-281-08, 65219-281-10, 65219-281-05, 65219-281-15
- Nui
- N0000183362, N0000175862
- Pharm class epc
- Gadolinium-based Contrast Agent [EPC]
- Pharm class moa
- Magnetic Resonance Contrast Activity [MoA]
- UNII
- 1BJ477IO2L
